戻る Agenda
S06 : The Future of Japan in Diversifying Global Drug Development
Session Chair(s)
Asuka Kawai
Manager, Clinical Projects Management, Kissei Pharmaceutical Co., Ltd., Japan
Speaker(s)
Kotone Matsuyama, RPH
Center for Clinical Research and Development, National Center for Child Health and Development, Japan
Michiyo Ohshima, MBA
Senior Director, Head of Japan Portfolio and Project Management, Pfizer R&D GK, Japan
Hisashi Koike, PHD
Review Director, Office of New Drug IV, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Tomoko Okudaira
Director of Personnel Coordination, Office of General Affairs, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Yukiko Komori
, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Keiko Katsui, PHD
Division of Biomedical Ethics and Social Co-Creation, Japan Agency for Medical Research and Development (AMED), Japan
Satoshi Suzuki, PMP
Director, Head of PM Office Group, Japan Portfolio & Project Management, Pfizer R&D Japan G.K., Japan